" /> " /> " />

Diabetes drug Avandia seeks clearance in Saudi

29 May 2010

According to Dr. Khalid Al-Rubeaan, director of the Diabetes Center at King Saud University (KSU), there is no scientific basis to ban Avandia, GlaxoSmithKline's (GSK) diabetes drug, which is said to be cleared soon by the Saudi Food and Drug Authority (SFDA), Arab News has reported. Last March, SFDA banned the Type 2 diabetes drug for six months, citing growing evidence from clinical studies indicating serious cardiovascular risks. "I think it was a wrong decision ... and I hope the SFDA will reverse the decision shortly," Dr Khalid added.

A MEED Subscription...

Subscribe or upgrade your current MEED.com package to support your strategic planning with the MENA region’s best source of business information. Proceed to our online shop below to find out more about the features in each package.

Get Notifications